Drug profile · INN
buspirone hydrochloride
BUSPIRONE HYDROCHLORIDE
buspirone hydrochloride (BUSPIRONE HYDROCHLORIDE) is a serotonin 1a (5-ht1a) receptor partial agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — buspirone hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 5
- Data quality
- 0.89
Quick answer
buspirone hydrochloride (BUSPIRONE HYDROCHLORIDE) is a serotonin 1a (5-ht1a) receptor partial agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin 1a (5-HT1a) receptor partial agonist
Primary target: 5-hydroxytryptamine receptor 1A
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is buspirone hydrochloride?
buspirone hydrochloride (BUSPIRONE HYDROCHLORIDE) is a serotonin 1a (5-ht1a) receptor partial agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for buspirone hydrochloride?
BUSPIRONE HYDROCHLORIDE is a marketed brand name for buspirone hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of buspirone hydrochloride?
buspirone hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.